Cytosorbents Corporation (NASDAQ:CTSO) stock has reached a notable milestone, hitting a 52-week high of $1.6, signaling a period of strong performance for the medical device company. According to ...

CytoSorbents Corp (NASDAQ:CTSO) is set to release its Q4 2024 earnings on Mar 6, 2025. The consensus estimate for Q4 2024 revenue is $10.10 million, and the earnings are expected to come in at -$0 ...

CytoSorbents (CTSO) announced that it is postponing its previously announced earnings call scheduled for March 6, 2025 to allow more time to complete the annual financial audit following the ...

Shares of CTSO opened at $1.06 on Friday. The business has a 50-day simple moving average of $1.03 and a two-hundred day simple moving average of $1.05. Cytosorbents has a 12-month low of $0.70 ...

Shares of CTSO stock opened at $1.30 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.58 and a current ratio of 1.97. Cytosorbents has a fifty-two week low of $0.70 ...

Short interest in CytoSorbents Corp (NASDAQ:CTSO) increased during the last reporting period, rising from 1.93M to 1.95M. This put 3.28% of the company's publicly available shares short.